Subscribe

Note: Remember to check your spam folder and also your promotions/social tabs for the confirmation email.

Get new posts by email:

Featured

Semaglutide: Artificial Shortage Is Novo Nordisk’s Business Model

In early February, drug company Novo Nordisk sued telehealth company Hims & Hers. The complaint: Hims & Hers sells GLP-1 drugs at lo...

Follow Me on Twitter